RHHVF:OTCMKTS
Roche Holding AG Genussscheine
$480.00
arrow_upward
+0.46%(+2.21) 1D
$480.00
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 19, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RHHVF...
Open
$477.66
High
$480.00
Low
$466.40
Mkt. cap
385.34B
Avg. vol.
4.92K
Volume
10.71K
52-wk high
$499.76
52-wk low
$357.30
Beta
0.47
Shares outstanding
702.56M
No. of employees
113K
Open
$477.66
High
$480.00
Low
$466.40
Mkt. cap
385.34B
Avg. vol.
4.92K
Volume
10.71K
52-wk high
$499.76
52-wk low
$357.30
Beta
0.47
Shares outstanding
702.56M
No. of employees
113K
News stories
From web sources and news partners
Yahoo! Finance Canada
·
1 hour ago
Roche Holding (SWX:ROP) Secures FDA Nod For Wilserdly And Expands Lab Testing Reach
ad-hoc-news.de
·
7 hours ago
Roche Holding stock: FDA approves Wilserdly for advanced breast cancer
Yahoo Finance
·
3 days ago
What Does Roche Holding (SWX:ROP) Gain From Gazyva’s New Kidney And Lupus Progress?
Investing.com
·
3 days ago
Roche receives FDA authorization for mass spectrometry platform
Profile
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in the Forbes Global 2000 was 76.
The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021.
F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations. Wikipedia
About Roche Holding AG Genussscheine
CEOThomas Schinecker
Employees113K
FoundedOct 1, 1896
HeadquartersBasel, Basel City, Switzerland
SectorHealth Care
IndustryPharmaceutical industry
Websiteroche.com